Diabetes Mellitus, Type 2, Heart Diseases
Conditions
Brief summary
The overall objective is to increase the adherence to national guidelines for patients with established CVD and/or Type 2 diabetes by means of repeated post-graduate educational meetings and regular evaluation of the optimisation initiatives, demonstrated by improvement of goal attainment in general practice.
Interventions
BEHAVIORALPatient adherence to national educational guidelines.
Sponsors
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Subjects had to meet all of the inclusion criteria to be eligible for enrollment into the study. The following subjects qualify for inclusion in the study: * Subjects for whom measurement of total cholesterol, low density lipoprotein (LDL) cholesterol, blood pressure (BP) and glycosylated hemoglobin (HbA1c) was planned independently of this observational study and for whom baseline values were or became available. * Subjects with known CVD diagnosed \> or = 6 months before inclusion * Previous myocardial infarction * Ischemic heart disease (stable and unstable angina pectoris) * Ischemic apoplexy * Peripheral arterial disease * And/Or * Subjects with T2D diagnosed \> or = 6 months before inclusion * At least 50% of the subjects had to have CVD as the primary diagnosis. It was allowed for a secondary diagnosis to be \<6 months before inclusion.
Exclusion criteria
* Subjects presenting with any of the following were not to be included in the study: * Life expectancy of \< or = 2 years * Unable/unwilling to understand/follow instructions * Taking part in a clinical study involving an investigational drug * Followed by a specialist for their CVD and/or T2D at the time of inclusion in the study
Outcome results
None listed